Eva Hoff Wanderås

539 total citations
9 papers, 379 citations indexed

About

Eva Hoff Wanderås is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eva Hoff Wanderås has authored 9 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eva Hoff Wanderås's work include Colorectal and Anal Carcinomas (4 papers), Testicular diseases and treatments (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). Eva Hoff Wanderås is often cited by papers focused on Colorectal and Anal Carcinomas (4 papers), Testicular diseases and treatments (3 papers) and Colorectal Cancer Surgical Treatments (3 papers). Eva Hoff Wanderås collaborates with scholars based in Norway, Sweden and Denmark. Eva Hoff Wanderås's co-authors include Lise Balteskard, Gunilla Frykholm, Marianne G. Guren, Tom Wilsgaard, Anne Gry Bentzen, Steinar Tretli, S.D. Fosså, Olav Dahl, S. Tretli and Tom Grotmol and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer and Radiotherapy and Oncology.

In The Last Decade

Eva Hoff Wanderås

9 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Hoff Wanderås Norway 7 334 139 123 62 50 9 379
Martijn F. Lutke Holzik Netherlands 8 415 1.2× 320 2.3× 88 0.7× 77 1.2× 38 0.8× 15 520
R. M. Bremnes Norway 4 81 0.2× 151 1.1× 142 1.2× 43 0.7× 27 0.5× 15 308
Imke Strohscheer Germany 6 171 0.5× 124 0.9× 46 0.4× 57 0.9× 52 1.0× 10 418
Ahmed Elghiaty South Korea 6 175 0.5× 45 0.3× 78 0.6× 44 0.7× 66 1.3× 9 243
Maryam Kadivar Iran 12 100 0.3× 121 0.9× 91 0.7× 29 0.5× 26 0.5× 40 341
R. Bastús Spain 9 397 1.2× 78 0.6× 133 1.1× 79 1.3× 43 0.9× 22 462
Carsten Rusner Germany 9 249 0.7× 30 0.2× 85 0.7× 65 1.0× 78 1.6× 18 328
Rodger M. Pryzant United States 5 128 0.4× 78 0.6× 60 0.5× 34 0.5× 71 1.4× 7 280
P Øgreid Norway 10 255 0.8× 67 0.5× 106 0.9× 40 0.6× 15 0.3× 21 346
Kerry Schaffer United States 9 84 0.3× 112 0.8× 88 0.7× 37 0.6× 24 0.5× 19 269

Countries citing papers authored by Eva Hoff Wanderås

Since Specialization
Citations

This map shows the geographic impact of Eva Hoff Wanderås's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hoff Wanderås with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hoff Wanderås more than expected).

Fields of papers citing papers by Eva Hoff Wanderås

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hoff Wanderås. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hoff Wanderås. The network helps show where Eva Hoff Wanderås may publish in the future.

Co-authorship network of co-authors of Eva Hoff Wanderås

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Hoff Wanderås. A scholar is included among the top collaborators of Eva Hoff Wanderås based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Hoff Wanderås. Eva Hoff Wanderås is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Guren, Marianne G., Oskar Hagberg, Bengt Glimelius, et al.. (2014). Anal carcinoma – Survival and recurrence in a large cohort of patients treated according to Nordic guidelines. Radiotherapy and Oncology. 113(3). 352–358. 43 indexed citations
2.
Bentzen, Anne Gry, Lise Balteskard, Eva Hoff Wanderås, et al.. (2013). Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivors. Acta Oncologica. 52(4). 736–744. 100 indexed citations
3.
Bentzen, Anne Gry, Marianne G. Guren, Barthold Vonen, et al.. (2013). Faecal incontinence after chemoradiotherapy in anal cancer survivors: Long-term results of a national cohort. Radiotherapy and Oncology. 108(1). 55–60. 51 indexed citations
4.
Bentzen, Anne Gry, Marianne G. Guren, Eva Hoff Wanderås, et al.. (2012). Chemoradiotherapy of Anal Carcinoma: Survival and Recurrence in an Unselected National Cohort. International Journal of Radiation Oncology*Biology*Physics. 83(2). e173–e180. 41 indexed citations
5.
Sørbye, Halfdan, Åke Berglund, Kjell Magne Tveit, et al.. (2007). Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer. Acta Oncologica. 46(7). 982–988. 11 indexed citations
6.
Hølmebakk, Toto, et al.. (2006). [Protective silicone prosthesis prior to radiotherapy of recurrent colonic cancer].. PubMed. 126(4). 447–9. 1 indexed citations
7.
8.
Wanderås, Eva Hoff, S.D. Fosså, & Steinar Tretli. (1997). Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 norwegian male patients. European Journal of Cancer. 33(2). 244–252. 73 indexed citations
9.
Wanderås, Eva Hoff, S. D. Fosså, Steinar Tretli, & Olbjørn Klepp. (1994). TOXICITY IN LONG-TERM SURVIVORS AFTER ADRIAMYCIN CONTAINING CHEMOTHERAPY OF MALIGNANT GERM-CELL TUMORS. International Journal of Oncology. 4(3). 681–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martijn F. Lutke Holzik Breakdown of academic impact, for papers by R. M. Bremnes Breakdown of academic impact, for papers by Imke Strohscheer Breakdown of academic impact, for papers by Ahmed Elghiaty Breakdown of academic impact, for papers by Maryam Kadivar Breakdown of academic impact, for papers by R. Bastús Breakdown of academic impact, for papers by Carsten Rusner Breakdown of academic impact, for papers by Rodger M. Pryzant Breakdown of academic impact, for papers by P Øgreid Breakdown of academic impact, for papers by Kerry Schaffer
Rankless by CCL
2026